Why Taiwan

Taiwan’s longstanding commitment to global trade and open markets is well known. The government has endeavored to create an infrastructure and regulatory framework that are conducive to the biomedical industry. A favorable location, open financial markets, sound financial institutions, low taxes, a reliable legal system, abundant foreign reserves, and talented people make Taiwan the perfect place for business.

Taiwan Delegation Event Schedule

Taiwan delegation with over 30 companies in new drug, CMO, regenerative medicine, agriculture biotechnology, precision medicine, and smart health fields are looking forward to meet you at BIO2019 in Philadelphia.

Taiwan pavilion booth numbers: 2511, 2609, and 2549.

Layout & Meeting Room Guide:


In addition, you are most welcome to join all Taiwan events during BIO2019.



Global Biotech Entrepreneur Taiwan Forum

We bring together global top experts for a day, on June 02, to present the latest developments and future outlook for innovative emerging biotechnologies of medical AI, regenerative medicine, and microbiome with top medical professionals, and investment insight from renowned venture capitalists, all in one place! Register now and reserve your seat as early as possible.


Date & Time:

08:30~18:00, Sun., June 2, 2019
Venue:
Science Education and Research Center (SERC), Temple University
1925 N. 12 St. 362 Suite 400, Carnell Hall, Philadelphia, PA 19122-6104, United States



Taiwan Pavilion Opening Ceremony

We bring together global top experts for a day, on June 02, to present the latest developments and future outlook for innovative emerging biotechnologies of medical AI, regenerative medicine, and microbiome with top medical professionals, and investment insight from renowned venture capitalists, all in one place! Register now and reserve your seat as early as possible.

Start at 4PM, June 4 in Taiwan pavilion (booth no. 2609). You can enjoy delicious snacks, tea, and meet with us!!

Date & Time:

16:00-17:00, Tue., June 4, 2019
Venue:
Taiwan Pavilion (Booth No.: 2609)

Taiwan Appreciation Cocktail Party

Please find attached file for invitation, RSVP.

Date & Time:
17:30, Tue., June 4, 2019
Venue:
Grand Ballroom, The Ritz Carlton Philadelphia

Download

Hub for Advanced Therapy in Asia Pacific-Ecosystem and Clinical Trial


Date & Time:
15:30-15:45, Wed., June 5, 2019
Venue:
Theater 4, Level 0

Delegations

Public Institutes

  • The Ministry of Health and Welfare of the Republic of China

    The Ministry of Health and Welfare of the Republic of China

    Company Description

    The Ministry of Health and Welfare of the Republic of China (MOHW) is the Executive Yuan ministry responsible and the highest authority for the administration of the public health system, social welfare, affordable and universal health care, hospitals, pharmaceutical, immunization programs, disease prevention, supervision and coordination of local health agencies in Taiwan. The MOHW was originally established on 17 March 1971 as the Department of Health (DOH). The department was upgraded to Ministry of Health and Welfare on 23 July 2013 with the addition from the agencies in the Ministry of the Interior responsible for social welfare following restructuring of the Executive Yuan. The mission of MOHW is to promote the health and well-being of all Taiwan citizens.

    The MOHW’s diversified responsibilities include health policy planning and promotion, prevention and control of disease, food safety, drug management, social insurance and welfare, relief and protective services. MOHW’s mandate also includes biotechnology R & D, international health cooperation, and diverse other areas affecting public health and well-being far beyond Taiwan. The MOHW will continue to pursue the goals of effective teamwork and coordinated planning for health and welfare services that meet changed needs of Taiwan citizens.

    Contact Information
    Name:
    Hsien-yang Lee
    Position:
    Researcher, Office of Science and Technology
    Tel:
    886-2-8590-7567
    Address:
    No.488, Sec. 6, Zhongxiao E. Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
    Sectors:
    To Promote the Health and Well-Being of all Taiwan Citizens
  • COUNCIL OF AGRICULTURE EXECUTIVE YUAN

    COUNCIL OF AGRICULTURE EXECUTIVE YUAN

    Company Description

    The Council of Agriculture is the competent authority on the agricultural, forestry, fishery, animal husbandry and food affairs in Taiwan. Its responsibilities include guiding and supervising provincial and municipal offices in these areas. It is committed to promoting the diversified value of agriculture, ensuring food security, preserving agro-ecological environment and cultural landscape, and creating a competitive LOHAS agriculture. The COA is leading the policies toward expediting agricultural structure adjustment, promoting ago-business management, boosting agricultural industry internationalization, activating agricultural resources, in order to ensure the sustainable development of agriculture in Taiwan.

    Contact Information
    Name:
    Meng-Fang Hsu
    Position:
    Associate Technical Specialist
    Tel:
    886-2-2312-4058
    Address:
    37 NAN HAI RD., TAIPEI,TAIWAN 10014 R.O.C.
    Sectors:
    Promoting sustainable agriculture in Taiwan
  • Department of Economic Development Taipei City Government

    Department of Economic Development Taipei City Government

    Company Description

    Taipei is the national hub for biotechnology and medical research.
    There are nearly 400 biotech companies in the city. The annual revenue of these companies is around 6 billion USD, accounting for 50% of that of Taiwan’s biotechnology industry. Academia Sinica and eight major medical centers are located in Taipei, while more than 20 universities and vocational colleges in the city have biotech departments.
    Taipei city is implementing the Nangang Biotech cluster BOT project which is scheduled to be completed in May 2023. Taipei City Government also provides one-stop services to incoming businesses that assist them in investment consultation and finding office space, subsidies and funding.

    Contact Information
    Name:
    Sun-Yi Yang
    Position:
    Section Assistant
    Tel:
    886-2-2720 8889 #6587
    Address:
    No. 1, City Hall Rd., Xinyi Dist., Taipei City 11008, Taiwan(R.O.C.)
    Sectors:
    Invest Taipei Office, Taipei City Government
  • Hsinchu Biomedical Science Park

    Hsinchu Biomedical Science Park

    Company Description

    Hsinchu Biomedical Science Park supports the development of new drugs R&D for diseases that are common in Asia, and of high-end medical devices. It integrates the nearby Hsinchu Science Park's ICT value chain with open lab and core facilities served by the National Laboratory to provide services fulfilling all possible demands of innovation entrepreneurs. The hospital under construction is expected to provide over 348 beds for medical treatments and clinical trials when phase 1 is completed in 2020. In addition, the Park will also develop featured clinics and medical services, and to provide craniofacial reconstruction, cardiovascular treatment, joint replacement and other exquisite medical treatments. The Biomedical Science Park is expected to pilot global biomedical industry technology development and turns out to be the model of biomedical science park in Asia.

    Contact Information
    Name:
    May Hsia
    Position:
    Research Associate
    Tel:
    886-3-577-3311
    Address:
    2 Hsin Ann Road, Hsinchu, 30016 Taiwan
    Sectors:
    New drugs, High-end medical devices, Featured Clinics
  • Central Taiwan Science Park

    Central Taiwan Science Park

    Company Description

    Central Taiwan Science Park (CTSP), as an emerging technology hub for innovation-driven industries, has formed an effective biotechnology cluster with high-tech companies focusing on medical & assistive devices, vaccines & drugs, dietary supplements, advanced agricultural products, etc.

    CTSP endeavors to facilitate the development of the biotech industry by fostering an environment where industrial, academic and medical resources are integrated. In response to the sustainable development in an ageing world, CTSP is fully committed to developing new solutions that better support public needs, such as minimally invasive surgical devices and intelligent assistive technologies.

    Contact Information
    Name:
    Yang-Chieh Lin
    Position:
    Park Receptionist
    Tel:
    886-4-25658588 #1120
    Address:
    No.2, Jhongke Rd., Situn District, Taichung City 40763, Taiwan
    Sectors:
    Investment Promotion Section,Central Taiwan Science Park Bureau,Ministry of Science and Technology
  • Southern Taiwan Science Park Bureau (STSPB)

    Southern Taiwan Science Park Bureau (STSPB)

    Company Description

    The Southern Taiwan Science Park, founded by the Taiwanese government in 1995, is one of the country’s most significant centers for biotech development and manufacture.

    The STSPB takes an active role in facilitating the biotech and business development by providing the tenant companies with a comprehensive service platform, integrating the academic, medical, industrial and research resources.

    Currently there are more than 70 companies in the medical device industry cluster, including stomatology, orthopedics, testing reagents, smart monitoring and other products, such as small molecule drugs, stem cells and traditional herbal medicines, etc.

    Contact Information
    Name:
    William Kuo
    Position:
    Section Chief
    Tel:
    886-6-5051001 ext. 2321
    Address:
    No. 22, Nanke 3rd Road, Xinshi District, Tainan City, 741-47, Taiwan, R.O.C
    Sectors:
    One-Stop Service, Research Ecosystem, Innovative Consultation, Platform for Industrial Development, Platform to Boost Clinic Reliability, International Marketing Service Platform
  • BioHub Taiwan

    BioHub Taiwan

    Company Description

    Get local & Go global! Biohub Taiwan is a collaborative effort by Academia Sinica, Ministry of Science and Technology, Ministry of Economic Affairs and Ministry of Health and Welfare, who have joined forces in Taiwan’s biomedical development. The integrative platform has been well-established and currently based in the Innovation Incubation Center of the National Biotechnology Research Park, Taipei. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech companies that will enable start-ups, students and faculty of academic units to nurture early ideas. Along the way, we maintain affordable lab and office space, mentoring, and a network of professional advisors. We also make every effort to supply venture capitals for entrepreneurs. It is believed that Taiwan will become the Asia Pacific’s premier biomedical research and development hub in the near future.

    Contact Information
    Name:
    I-CHIEN JAN
    Position:
    Assistant CEO of BioHub Taiwan
    Tel:
    886-2-2788-7128
    Address:
    Rm. 123, No.99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C)
    Sectors:
    Innovation Incubation Center, Accelerators, Venture Capital, Start-ups
  • Taiwan External Trade Development Council (TAITRA)

    Taiwan External Trade Development Council (TAITRA)

    Company Description

    Founded in 1970, TAITRA has developed a well-coordinated trade promotion and information network composed of over 1,300 trained specialists stationed at its headquarters in Taipei, in five local branch offices in Taoyuan, Hsinchu, Taichung, Tainan, and Kaohsiung, as well as in over 60 representative offices around the world.

    In association with its sister organizations, the Taiwan Trade Center, Inc. (TTC) and the Taipei World Trade Center (TWTC), TAITRA continues to do everything possible to adapt its trade promotion strategies to the changing international trends and conditions. TAITRA's major functions include Market Development, Strategic Marketing, Trade Information Services, Exhibitions, Convention Services, Trade Education, and Taiwan Trade (an e-Trading Hub service).

    Contact Information
    Tel:
    886-2-2725-5200
    Address:
    4-7 Fl., 333 Keelung Rd., Sec. 1, Taipei 11012, Taiwan
    Sectors:
    Market Development, Strategic Marketing, Trade Information Services, Exhibitions, Convention Services, Trade Education, and Taiwan Trade (an e-Trading Hub service)
  • Taiwan Stock Exchange

    Taiwan Stock Exchange

    Company Description

    The Taiwan Stock Exchange (TWSE) started operation on Feb. 1962. With the objective of creating a fair, efficient and safe trading environment, the TWSE operates in line with government policy to develop a healthy securities market.

    Products listed on the TWSE include Taiwan Depository Receipts (TDRs), Warrants, Stocks and Exchange Traded Funds (ETFs). As of 2018, there were 945 listed companies (including TDRs) with a total market capitalization around US$ 1 trillion, and ranked No. 17 in the world.

    TWSE, through its listing advisory guidance and market oversight functions, actively promotes sustainable operation of listed companies with a special focus on economic development, social responsibility, and environment sustainability.

    Contact Information
    Name:
    Kuo, Nai-Yu
    Position:
    Associate, Foreign Listing Department
    Tel:
    886-8101-3627
    Address:
    11F, No.7, Sec.5, Xinyi Rd., Taipei City 11049, Taiwan (R.O.C.)
    Sectors:
    Financial Service, Capital Market
  • Taipei Exchange

    Taipei Exchange

    Company Description

    Taipei Exchange (TPEx) is an integrated and multifunctional exchange founded in 1994. TPEx has been an official member of the World Federation of Exchanges (WFE) since 2011. TPEx has built an efficient fund-raising platform that supports the growth of small and medium-sized enterprises and helps mid-sized corporations become stronger. Our market provides a tiered structure, which ranges from the micro-enterprise supporting Go Incubation Board for Startup and Acceleration Firms (GISA), to the Emerging Stock Board (ESB) for negotiated-price trading of pre-IPO companies, and on to the Mainboard (MB) for trading more established companies. This GISA to ESB to MB structure supports enterprises’ growth through all their stages of development and has contributed to the strong growth of Taiwan’s capital markets.

    Contact Information
    Name:
    Leo Liu
    Position:
    Manager, Listing Examination Department
    Tel:
    886-2-2366 5903
    Address:
    15F, No. 100, Sec. 2, Roosevelt Road, Taipei City 10084, Taiwan (R.O.C.)
    Sectors:
    Stock Market, Bond Market and Derivatives Market
  • Taiwan Bio Industry Organization (BIO Asia-Taiwan 2019)

    Taiwan Bio Industry Organization (BIO Asia-Taiwan 2019)

    Company Description

    Since its founding in 1989, the Taiwan Bio Industry Organization has been working closely with industry, government departments and academia to promote biotechnology and its contribution to Taiwan's economy and the health of its people. 100+ organizations and 3,000+ individuals make up membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors.

    TBIO organize the annual BioTaiwan conferences and exhibition, the largest gathering of biotechnology industry in Taiwan. In 2019, the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan Bio) have come together to present BIO Asia-Taiwan, taking place July 24-28 in Taipei.

    Contact Information
    Name:
    Bor-Fuei "Apo" Huang
    Position:
    Secretary General
    Tel:
    886-2-7700-3883
    Address:
    Bldg. E, No.107, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei, Taiwan
    Sectors:
    ‧Promoting international exchange and cooperation
    ‧Promoting communication between government and industry
    ‧Cultivating biotechnology industry talent
    ‧Encouraging outstanding performance and innovation
    ‧BIO Asia-Taiwan 2019 July 24-28

Research Institutes

GLORIA Taiwan

  • China Medical University, GLORIA, Taiwan

    China Medical University, GLORIA, Taiwan

    Company Description

    The ambition of the ABBA is to nurture the first Taiwan Unicorn Enterprise in the healthcare field by integrating smart medical service, minimal-invasive surgery, intelligent medical devices, and healthcare-life sciences-blockchain. With the joint efforts of international innovative intelligences and Capitalists, we are aiming to creating a magnetic platform for the entire Taiwan health industry. The ABBA is powered by the International Clinical Trial Center and the diversified calibers of research engine reside in the China Medical University and Asia University. We are providing members service of bridging the R&D and manpower needs for Cell/Immune therapy, Precision Medicine, biophamaceutics, AI-based healthcare management, smart medical devices, and healthcare blockchain. ABBA vision to create the interests margin by powered biomedical products, international investment, and linking global Innovation and entrepreneurship. ABBA should expedite to fulfill the thirsty in the expanding market health industry in Taiwan.

    Contact Information
    Name:
    Chen, Sheng Chin
    Position:
    Chief Operating Officer
    Tel:
    886-2-22967979 #1580
    Address:
    No.91, Hsueh-Shih Road, Taichung, Taiwan
    Sectors:
    Biomedical technology research and development
  • Chung Yuan Christian University, GLORIA, Taiwan

    Chung Yuan Christian University, GLORIA, Taiwan

    Company Description

    Center For Membrane Technology (CMT) is independently established as an R&D institute who focuses on membrane separation for both industrial and biomedical applications, under the name of Chung Yuan Christian University (CYCU) in Taiwan. The ongoing pioneering technology development is our "Zwitterionic Surface Modification" (ZWI-TECH), which is able to apply onto surfaces of different materials, in order to render a surface property called super-hydrophilicity, which turns into anti-biofouling surfaces. With a water contact angle reaching 0 degree, the modified surface becomes super-hydrophilic and biofouling (which starts with non-specific binding of proteins) is optimally prevented. This technology holds infinite possibilities over fields of application including but not limited to bio-processings, fermentations, medical implants, marines, cosmetics, blood treatment and so on.

    Contact Information
    Name:
    Yung Chang
    Position:
    Director
    Tel:
    886-915-576167
    Address:
    No. 493, Xinzhong N. Rd., Zhongli Dist., Taoyuan City 32023, Taiwan (R.O.C.)
    Sectors:
    ‧Academic/Non-Profit > Research Institute
    ‧Academic/Non-Profit > Tech Transfer
    ‧Academic/Non-Profit > University (Faculty)
    ‧Industrial/Environmental > Environmental
    ‧Industrial/Environmental > Industrial Chemicals/Products
  • National Central University, GLORIA, Taiwan

    National Central University, GLORIA, Taiwan

    Company Description

    Centered on the National Central University, NCU GLORIA focuses on advanced technology fields to facilitate industry-academia collaboration by linking NCU with the global market while providing industries with talents and scientific research services. The GLORIA Project accelerates global industry-academia collaboration by combining NCU’s research capability with industry partners, alumni support, and resources from various industry alliances. NCU possesses biomedical-related technologies across multiple healthcare disciplines, specifically in the fields of preventive medicine, diagnostics & evaluation, innovative therapy, and rehabilitation & learning in various medical settings.

    Contact Information
    Name:
    Yamin Kao
    Position:
    Manager
    Tel:
    886-4227151 ext #27079
    Address:
    No. 300, Zhongda Rd., Zhongli District Taoyuan City 32001, Taiwan
    Sectors:
    Industry-Academia Collaboration, Tech Transfer, Licensing, and Talent & Internship
  • National Cheng Kung University, GLORIA, Taiwan

    National Cheng Kung University, GLORIA, Taiwan

    Company Description

    GLORIA at NCKU is forging and strengthening mutually beneficial relationships between the institution and corporations worldwide.

    ‧We offer tailored research from NCKU, along with partners in Taiwan and members of the global alliance, to spur opportunities for enterprises. ‧We offer members access to NCKU’s global network, including industry-academic resource centers in Southeast Asian Nations. ‧The NCKU alumni in North America can promote R&D achievements in New York and Silicon Valley across a broad spectrum of industries. ‧We give an enterprise’s employees the training they need to take on new challenges. ‧Our industry clusters enhance enterprise-to-enterprise communication and put promising ideas and R&D innovations on the fast track to the global market.

    Contact Information
    Name:
    William Hung
    Position:
    Chief Operations Officer
    Tel:
    886-6-2080325 #200
    Address:
    No.1, University Road, Tainan City 701, Taiwan (R.O.C)
    Sectors:
    Tailored Research, Global Network, Talent Pool, Professional Education and Industry Clusters
  • National Chung Hsing University, GLORIA, Taiwan

    National Chung Hsing University, GLORIA, Taiwan

    Company Description

    National Chung Hsing University (NCHU), the leading research university in central Taiwan, will celebrate its 100th anniversary in 2019. Our faculty and alumni are the industrial leaders of innovation and incubation in central Taiwan and focus their leaderships on research and technology in agriculture, biotechnology, veterinary medicine, artificial intelligence, precision machinery, renewable energy and materials, circular economy, and cultural and creative industry.

    As a leading institution in the development of agriculture field, the NCHU has its core competency in New Agriculture, including sustainability and recycling economy. The College of Agriculture and Natural Resources, the College of Veterinary Medicine, and the College of Life Science at the NCHU have accumulated abundant R&D achievements, by increasing the added value of agriculture and incorporating with the Industry 4.0, to establish the future of New Agriculture. The Alliance has divided its focus and services into five areas: creating new businesses, matchmaking industry-university collaboration projects, technology transfer, recruiting Alliance members, and cultivation of international talents.

    Contact Information
    Name:
    Heather Huang
    Position:
    Business Development Manager
    Tel:
    886-4-22840558 ext.31
    Address:
    145 Xingda Rd., South Dist., Taichung City 402, Taiwan (R.O.C.)
    Sectors:
    NCHU specializes in the fields of agri-biotechnology, veterinary medicine, biomedical health care, people's livelihood chemicals and food industry. The NCHU and the Alliance provide professional services to the members, including but not limited to R&D collaboration and counseling, to create a win-win situation for the university and the industry.
    NCHU GLORIA focuses on:
    ‧Talent matching
    ‧Results Presentation of Core Technology
    ‧International Technology Forum & Cooperation Matching
    ‧Co-R&D via NCHU Research Resources
    ‧Innovation and Incubation Center
  • National Sun Yat-sen University, GLORIA, Taiwan

    National Sun Yat-sen University, GLORIA, Taiwan

    Company Description

    National Sun Yat-sen University, Gloria, Taiwan is the largest scale of R&D platform in Taiwan. We offer talent acquisition, technology sourcing, Consulting services, Cross-domain Technologies from universities to industries. Led by National Sun Yat -Sen University, we are comprised of 6 universities of Southern Taiwan, including KMU, NKUST, NUK, NPUST and ISU Universities. We promote the R&D outcomes of Materials technology, Smart Medicine & Healthcare, Marine technology, and Agriculture technology. Except to help to accelerate cross industry innovation, we also focus on the realistic demands of the members, foresee the pioneer technology by utilizing the resources of the alliance to provide suitable solutions.

    Contact Information
    Name:
    Elsa Chung
    Position:
    Senior Manager
    Tel:
    886-7-5252000 #2690
    Address:
    IR 6017, No.70, Lienhai Road, Gushan District,Kaohsiung, Taiwan
    Sectors:
    Academia/University
  • NNational Taiwan Ocean University, GLORIA, Taiwan

    National Taiwan Ocean University, GLORIA, Taiwan

    Company Description

    As a worldwide leading academic institute in the field of marine science and technology, the NTOU GLORIA is well known for both its research achievements and tight partnerships with the industry. NTOU GLORIA serves as a platform further bridging the academia and industry sectors through forming a strong alliance with resources from both sectors and assets from NTOU’s resourceful alumni and partner research institutes. NTOU GlORIA focuses on four major fields: healthy fingerlings, novel additives, AIoT, and Bio-security. The GLORIA provides customized services to the industrial partners to meet their specific needs to grow business.

    Contact Information
    Name:
    Jessie Huang
    Position:
    Manager
    Tel:
    886-2-29622192 #2297
    Address:
    No. 2, Beining Rd., Zhongzheng Dist., Keelung City 202, Taiwan (R.O.C.)
    Sectors:
    Aquaculture and biotechnology business consultant, Matching-service platform of aquaculture and biotechnology
  • National Taiwan University, GLORIA, Taiwan

    National Taiwan University, GLORIA, Taiwan

    Company Description

    The National Taiwan University, GLORIA, Taiwan is one of the Ministry of Science and Technology subsidized bodies through the Global Research & Industry Alliance program(GLORIA). NTU GLORIA is the best one and the only one combined, cross-sector and multi-themed GLORIA.

    NTU GLORIA was established as a mutual benefitting bridge between the industry and National Taiwan University. It integrates National Taiwan University’s research momentum (currently consisting of 11 colleges and 3 professional colleges, 5 international, 7 national and 46 institute level research center) and provides memberships with National Taiwan University’s cross-sector, cross-industry development technology and talent resources.

    NTU GLORIA also acts as a platform that integrates the school industry related bodies, including the Center of Industrial Academic Cooperation, NTU Innovation Incubation Center, Taidah Entrepreneurship Center, Career Center – NTU Office of Student Affairs etc. As a matching window for National Taiwan University and the industry, the National Taiwan University Industry Liaison Office offers memberships with integrated industry-academia co-operation services.

    Contact Information
    Name:
    Liu, Shih-Hao
    Position:
    Industry Liaison Manager
    Tel:
    886-2-3366-8286 #22
    Address:
    Complex for Research Excellence 5F, No.18, Siyuan St., Zhongzheng Dist., Taipei City 10087, Taiwan (R.O.C.)
    Sectors:
    Industry-academia collaboration, Startup opportunities, Talents matchmaking, Technical consulting, Lab equipment rental, Seminar, Database, Education promotion
  • National Taiwan University of Science & Technology, GLORIA, Taiwan

    National Taiwan University of Science & Technology, GLORIA, Taiwan

    Company Description

    With the spirit of “Practice-Oriented Education”, Taiwan Tech is acknowledged as a leading pioneer among technologically advanced universities in Taiwan. It is home to provide innovative and key technologies to the global market. Taiwan Tech GLORIA has been supporting Taiwan Tech’s research and is dedicated to integrating industry-university-government high tech ecosystem under one roof to boost beneficially bilateral and multilateral cooperation in cutting edge technology fields. Taiwan Tech GLORIA provides “One-Stop Consulting Service” to our members and customized marketing service programs based on their needs to minimize initial barriers of entry and help them to uncover new opportunities in the market. We believe that a good platform of knowledge exchange and mobilization requires more than one leaders. Therefore, it is essential to ally partnerships with both private and public sectors in upgrading the quality and increasing the influence. With the commitment of promoting collaboration between university and industry, Taiwan Tech GLORIA will continuously play a vital role and devote ourselves to meet the needs of our faculty and corporate partners to accelerate advances in technology and knowledge discovery.

    Contact Information
    Name:
    Dr. Alex Wei
    Position:
    CEO
    Tel:
    886-2-2730-3688~9
    Address:
    TR11F, No. 43, Sec 4, Keeling Rd., Taipei City, 10607 Taiwan
    Sectors:
    Nanotechnology, Computer Vision & Medical Imaging, Industry 4.0, Power Electronics Technology & Sustainable Energy
  • National Tsing Hua University, GLORIA, Taiwan

    National Tsing Hua University, GLORIA, Taiwan

    Company Description

    The aim for National Tsing Hua Global Research and Industry Alliance (GLORIA) is to expand international academia-industry collaboration by compiling industry-university R&D capacity of NTHU and eight partner universities in five major fields, including Smart Manufacturing Industry, IoT and AI Industry, Semiconductor and IC Design Industry, Biomedical and Health-Care Industry, and Creative Arts and Lifestyles Industry. The alliance will collaborate with the NTHU R&D team on the Translational Research Project to implement technology commercialization; thus verifies the feasibility of advance technology concepts or field trials for possibilities of mass production of a matured technology. The platform of alliance serves to introduce professional talents to domestic and foreign companies in accordance with their needs (RAISE Project and long-term internship programs). The alliance is in charge of promoting technology transfer and patent licensing in collaboration with the Innovative Incubation Center and Division of Intellectual Property and Technology Licensing.


    Contact Information
    Name:
    Rex Wu
    Position:
    Director
    Tel:
    886-3-5715131 ext.35186
    Address:
    GLORIA Operation Center, No.101, Sec.2, Guangfu Rd., Hsinchu City, Taiwan R.O.C.
    Sectors:
    Incubation center, Academia, Medical Technology
  • National Yang-Ming University, GLORIA, Taiwan

    National Yang-Ming University, GLORIA, Taiwan

    Company Description

    National Yang-Ming University (NYMU) was established in 1974 dedicated to medical doctor training and promoted to the first medicine-oriented comprehensive university in Taiwan since 1994. Six research arears are covered in NYMU including cancer research, brain research, preventive medicine, drug discovery, biomedical research, ageing as well as bioinformatics.
    GLORIA (Global Research & Industry Alliance)-NYMU was established since 2017 to better strengthen research achievements linkage to industrial applications. GLORIA aims to integrate research achievements within NYMU to initiate industry-university cooperation following licensing and co-development opportunities globally. GLORIA also offers financial consultation assistance for NYMU spin-off startup company.

    Contact Information
    Name:
    Tom Tseng
    Position:
    Industrial Liaison Manager
    Tel:
    886-2-28211492
    Address:
    Zhi-He Building, 2F, No.155, Sec.2, Linong St., Beitou Dist., Taipei City 112, Taiwan
    Sectors:
    Academic, cancer research, brain research, preventive medicine, drug discovery, biomedical research, ageing, bioinformatics
  • Taipei Medical University, GLORIA, Taiwan

    Taipei Medical University, GLORIA, Taiwan

    Company Description

    Taipei Medical University (TMU) is a collegiate academic institution with an extensive history in Taiwan.

    Established in 1960, over the past half-century, TMU was able to grow under challenging circumstances without regular official budget from the government or funding from foundations. It underwent the processes to building the foundation, flourishing, expansion and transformation via innovation. Today, TMU has expanded into a world-class university with eleven colleges, 6,000 students per year, six hospitals (TMU hospital, Wan Fang Medical Center, Shuang Ho Hospital, Taipei Cancer Center, Taipei Neuroscience Institute, and TMU NingBo medical Center), and more than 40,000 alumni around the world, serving the society and humankind and also cultivating the future talents for the nation. These are TMU’s most concrete contributions and also its most important responsibility and mission.

    In recent years, TMU has been honing its management while seeking breakthroughs and innovations. The University has experienced growth and progress in teaching, research, service, etc. and it has garnered unanimous recognition at home and abroad.

    Contact Information
    Name:
    Steven Hsu
    Position:
    Associate Dean
    Tel:
    886-2-2736-1661
    Address:
    250 Wuxing St. Taipei 11031, Taiwan
    Sectors:
    Medical University, Academic institutions, JCI Hospitals

Companies

  • ACRO Biomedical Co., Ltd.

    ACRO Biomedical Co., Ltd.

    Company Description

    ACRO Biomedical was founded in June 2014, and is positioning in developing and producing biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fats and non-collagenous proteins from animal tissues and organs, while keeping the undiminished collagen scaffold as the biomaterials for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc.

    Contact Information
    Name:
    Patricia Wu
    Position:
    Special Assistant to CEO
    Tel:
    886-7-6955569
    Address:
    3rd Fl., No. 57, Luke 2nd Rd., Lujhu Dist., Kaohsiung City 82151, Taiwan
    Sectors:
    Medical Device, Biomaterial, Tissue Engineering and Regenerative Medicine
  • APrevent Medical Inc.

    APrevent Medical Inc.

    Company Description

    APrevent Medical Inc. has offices in Taiwan (AspirEx Medical Ltd.) and Austria (APrevent Biotech GmbH). APrevent Biotech GmbH is ISO 13485 certified for design, manufacturing, and distribution of medical devices. Our core mission is to develop innovative medical products for unmet clinical needs.

    APrevent's products improve voice and communication, focusing on the development of a long-term implant system and speech conversion platform for patients with glottis insufficiency and dysarthria. We are dedicated to providing minimally invasive and innovative ENT implant and Software-as-a-Service (SaaS) technologies for voice & speech disorders, which are patient-orientated, physician friendly and improve the quality of lives around the world.

    APrevent has a diverse team of clinically experienced physicians, bio-mechanical and software engineers, and researchers with deep industry expertise committed to creating vocal identities. Our developments are well IP protected; we also cooperate with international key opinion leaders. These make APrevent's product enter the market as soon as possible and create maximum market value.

    Aprevent® Vocal Implant System (VOIS) An innovative adjustable implant to treat glottic insufficiency and prevent aspiration pneumonia. VOIS is now the smallest adjustable patient-specific implant to treat glottic insufficiency/unilateral vocal fold paralysis, VOIS can fine-tuning to achieve optimal outcomes and restore voice-specific spectrum profile. The total addressable market is $ 4.1B USD.

    Aprevent® Intelligible Speak (AiSpeak) AiSpeak is an artificial intelligible dysarthric speech conversion platform, it helps people who suffer from dysarthria including stroke, cerebral palsy, Parkinson’s disease and brain tumor patients to communicate and operate devices by voice. The potential market is $ 9B USD.

    In order to increase the database, we are collecting voice from different types of patients. We now cooperate with several medical institutions in Taiwan and Cleveland clinic in the US to develop Chinese and English dysarthria speech conversion platform. To speed up the development, we cooperate with academic institutions in Taiwan. Acknowledgments: we special thank National Chung Cheng University National Yang-Ming University.

    Taiwan FDA Product Registration and Marketing Strategy Service APrevent provides medical device in-country representative and registration service and medical device market channel planning to accelerate imported product launching to market.

    Contact Information
    Name:
    Elvy Fan
    Position:
    Sales Manager
    Tel:
    886-2-85011101 #771
    Address:
    Austria Office: Im letten 3a, Feldkirch, Austria
    Taiwan Office: ZhongShan District, Lequn 2nd Rd, No. 187, 7th Floor Taipei, 10487 TW
    Sectors:
    ENT Medical device and AI speech conversion research, development, product distribution and service.
  • AQUAVAN TECHNOLOGY CO., LTD.

    AQUAVAN TECHNOLOGY CO., LTD.

    Company Description

    The platform developed by Aquavan gives novel and effective new molecular entities for unmet medical needs. For instance, Taiwan Wild Bitter Melon which is cultivated by Taiwan government, organically planted and extracted by Aquavan, has proved its efficacy in controlling diabetes. Several molecules that were found and purified via Aquavan platform show awesome anti-cancer results in breast cancer and colon-rectal cancer. The Phase I clinical study will be conducted in 2021. More than 500 herbs information have been stored in Aquavan’s data base, based on these big data, Aquavan had already built a data base which contains more than 3,000 targets. Aquavan expects to discover more candidates to meet the unmet medical demand in the near future.

    Contact Information
    Name:
    Yvonne Huang
    Position:
    General Manager, International Business
    Tel:
    886-936-840-167
    Address:
    Rm.2,10F, NO.3, PARK ST., NANGANG, TAIPEI, TAIWAN
    Sectors:
    -Drug Discovery: New molecular/candidate finding, focused on: Oncology /Cardiovascular disease/COPD/Diabetes
    -Consultant service: Extraction/Purification, Mass Production .
  • Bioguard Corporation

    Bioguard Corporation

    Company Description

    Bioguard is a global animal health diagnostic company. We are dedicated to providing thorough animal disease diagnostic services and manufacturing various diagnostic test kits. Our name, Bioguard, it’s a combination of biology and guard. Along with our corporate motto, “Science for animal care”, it signals our company’s dedication to protecting animal health with our technologies and accurate, professional help. We provides animal disease diagnostic services and products. Our animal health diagnostic center is the first and only ISO/IEC 17025 accredited animal disease testing laboratory in Taiwan and China, which demonstrated that Bioguard meets international standards. Our canine/ feline diagnostic test kits are developed and produced by ourselves, and monitored by our research teams, including molecular biologists, clinical veterinarians and medical technologists. With our research teams, we not only support veterinarians with our diagnostic services, but also bring the frontiers of knowledge and technology to veterinarians and pet owners.

    Contact Information
    Name:
    HSU, CHING-CHEN
    Position:
    Project Manger
    Tel:
    886-2-55916688
    Address:
    6F, No.20-1, Wu-kong 5th Rd., New Taipei Industrial Park, New Taipei City 24890, Taiwan
    Sectors:
    Animal disease diagnostic kits, animal disease diagnostic services
  • CC Biotechnology Corporation

    CC Biotechnology Corporation

    Company Description

    CC Biotechnology Corporation was founded in 2012. CC Bio, an ISO certified company, is specializing in Drug Delivery System. We have whole product line with R&D and Manufacture in Taiwan. CC Bio new facility of total 36,000 square-feet on one floor is capable to handle extensive production volumes from market demands. We provide up to date and continuous improvements for the overall and consistent Quality System in order to meeting all critical requirements ISO13485, FDA21 CFR820 and GMP. The products are developed by our own R&D team, and have been highly approved by our customers.

    Contact Information
    Name:
    Joy Lin
    Position:
    Sales assistant
    Tel:
    886-6-3845868
    Address:
    No.68, Gongye 5th Rd., Annan Dist., Tainan City 709, Taiwan
    Sectors:
    Auto injector, pen injector, electronic injector, safety needle
  • EirGenix, Inc.

    EirGenix, Inc.

    Company Description

    EirGenix, Inc. (Stock Code: 6589) was founded in 2012 for the purpose of acquiring the spin-off unit of cGMP biopharmaceutical pilot facility from the Development Center for Biotechnology (DCB) in Taiwan. Formosa Laboratories has been one of EirGenix’s major investors and a strategic partner since its inception. EirGenix has raised more than ~100 million US dollars since its inception. EirGenix is in the process of completing its IPO process to be listed in the TPEx.

    The company operates two business units, a CDMO unit providing biopharmaceutical contract development and manufacturing services and a product unit developing high quality and affordable biosimilars to the benefits of patients around the global.

    EirGenix owned 2 cGMP facilities (one mammalian, one microbial) in New Taipei City. Another commercial production facility with the scale of twelve (12) 2000 L single use bioreactor systems in Zhubei, Northern Taiwan was on stream for production on the 23rd of January, 2019. Endowed with such indispensable resources, EirGenix is capable of biopharmaceutical activities from pre-clinical research to NDA. The strategy to phase the expansion of the plant’s production is to allow it to organically grow with the company’s future needs, which will be fueled by rising domestic and foreign demand for EirGenix’s services as a contract development and manufacturing organization (CDMO), and its own proprietary drug products.

    EirGenix is committed to providing client-centric products and services to ensure our customers achieve their business goals. Our dedicated team of professionals work closely with our clients to ensure that our clients receive the highest-quality products and services that are both timely and cost-effective. By striving to be a responsible and reliable service provider, we hope to build lasting and mutually-productive partnerships with our clients.

    EirGenix has received numerous awards, most recently including “Asia’s Best CMO” awarded in 2018 by Biologics Manufacturing Asia (BMA) and Best BioProcessing Excellence in Taiwan Award in 2019 6th Annual Biologics Manufacturing Asia

    Contact Information
    Name:
    CHIH JUNG CHANG
    Position:
    Unit Vice President
    Tel:
    886-2-7708-0123
    Address:
    No. 101, Lane 169, Kangning St., Xizhi Dist, New Taipei City 22180, Taiwan, R.O.C
    Sectors:
    ‧Cell Line Development & Cell Banking Service:
    -From DNA to stable cell lines includes CHO cell (CHO-S and CHO-K1), E. Coli, and Pichia.
    -MCB/ WCB/ EPC production

    ‧Contract Development & Manufacturing Service:
    -Development and optimization for upstream & downstream process
    -Manufacture microbial (150L)and mammalian cell-(200L/500L/1000L/2000L) based biologics compliant with PIC/S GMP standard

    ‧QC Analysis Service:
    -Provide analytical method development, qualification, and validation
    -Analysis includes identification, quantification, purity, potency, impurity, safety…etc

    ‧Antibody Drug Conjugate (ADC) Service: partnering with Formosa Laboratories, Ltd.
  • Foresee Pharmaceuticals Co., Ltd.

    Foresee Pharmaceuticals Co., Ltd.

    Company Description

    Company Profile:
    Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange. Foresee’s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology and derived drug products targeting specialty markets, and its first-in-class NCE programs targeting disease areas with high unmet needs.

    Product / Service:
    Foresee's product portfolio includes late stage and early stage programs such as FP-001, 6-month and 3-month, stable, ready-to-use versions of leuprolide mesylate injectable suspension (LMIS), for which regulatory submissions are planned in 2019; FP-025, a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in a Phase 2 proof-of-concept study; FP-045, a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently in planning (Fanconi Anemia; mitochondrial-mediated diseases); and FP-004, a novel, subcutaneously injectable depot product in development for the treatment of opioid use disorder and pain.

    Contact Information
    Name:
    Mathieu Boudreau / An Chung
    Position:
    Vice President, Business Development. / Public Relations/Investor Relations
    Tel:
    886-2-7750-0188
    Address:
    9F.-2, No.19-3, Sanchong Rd., Nangang Dist., Taipei City, Taiwan
    Sectors:
    Drug development and repurposing
  • GlycoNex Inc.

    GlycoNex Inc.

    Company Description

    GlycoNex specializes in the discovery and the development of antibody-based therapeutics. With a specific focus on glycan-directed cancer therapies, GlycoNex has established an anti-glycan antibody bank, which includes 50+ antibodies.

    GlycoNex has developed a comprehensive platform for antibody development, which covers plasmid constructions, stable cell line development, analytical development and all the way to the 50L-production. Based on this platform, GlycoNex has created different types of products including innovative antibodies, biosimilars (ex. Denosumab), and Fc-fusion protein. GlycoNex is looking for opportunities to license products out or co-develop with partners.

    Contact Information
    Name:
    Chun-Fu Lin
    Position:
    Director, Manufacture
    Tel:
    886-2-2697-4168 #133
    Address:
    8F, No. 97, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan 22175
    Sectors:
    Antibody Drug Development, Biosimilar, CDMO Service, Monosaccharide Analysis, Antibody Characterization
  • Health Ever Bio-Tech Co., Ltd.

    Health Ever Bio-Tech Co., Ltd.

    Company Description

    Health Ever Bio-Tech Co., Ltd. (HEB) was established to focus on the research and development of innovative botanical drugs backed with scientific and medical evidences for today’s great unmet medical needs. With in-house ISO/IEC 17025 certified laboratory and PIC/S GMP manufacturing facility, HEB has been actively involved in the preclinical and clinical development of botanical new drugs that have been verified effective and safe on animal, cellular and human studies. HEB has built a network of domestic and international scientific advisors and consultants who are top-notch in the industry to maximize the success and quality of our pipeline. HEB endeavors to provide botanical new drugs of the best quality and makes strenuous efforts to improve the health of our compatriots.

    Contact Information
    Name:
    Alex Chen
    Position:
    Business Development Director
    Tel:
    886-2-2732-5205
    Address:
    5F-6, No.51, Sec. 2, Keelung Rd., Xinyi Dist., Taipei City 110, Taiwan
    Sectors:
    Research and development of botanical new drugs
  • Leadgene Biomedical, Inc.

    Leadgene Biomedical, Inc.

    Company Description

    Established in 2013, Leadgene Biomedical, Inc. is a company specializing in immunotechnology and especially in monoclonal antibody and protein development. We focus on the development of monoclonal antibody and application platforms, including IVD kit development and antibody drug development, as well as related reagents for both academic research and in vitro diagnostics use.

    We have expanded our expertise to several fields, providing comprehensive technology from gene to protein, antibody applications, and various immunoassay platforms. In addition, we serve as a connection between the upstream and downstream chain groups all over the world through our technology and industrial value.

    Based on a high level of expertise and exclusive technologies, Leadgene provides the best quality products to our customers and offers a wide range of customized service according to clients’ specification.

    We are devoted to delivering the highest quality products and premium services that meet the needs and demands of our customers.

    Contact Information
    Name:
    Louis Yu-Wei Cheng
    Position:
    CEO
    Tel:
    886-6-2531538 ext.203
    Address:
    No.9, Ln. 147, Zhengbei 1st Rd., Yongkang Dist., Tainan City 71042, Taiwan.
    Sectors:
    Industry in vitro diagnostic kit R&D and manufacture, antibody pro-drug development, customized service (antibody development, humanization)
  • LiteMed Inc

    LiteMed Inc

    Company Description

    Lite-Med Inc., founded in 1991, is one of the best Medical Equipment Manufacturer in Taiwan. As a technical oriented company, we are specialized in the technology of Shock Wave, Image Processing, Medical UI design etc. We successfully integrated Computer, Precision Machinery and Semiconductor Automatic Control to achieve the most advanced ESWL (Extracorporeal Shock Wave Lithotripter) all over the world. ESWL is a non-invasive machine esp. for the treatment of Kidney & Ureter Stone. You are mostly welcomed to find the feature of our ESWL from following link.
    https://www.youtube.com/watch?v=QC31qd4Uluc
    Our ESWL has been certified by GMP, ISO13485, CE, FDA and TFDA etc. We are looking for the professional party from different country to be our distributor!

    Contact Information
    Name:
    Jenny Hu
    Position:
    Sales Vice President
    Tel:
    886-2-2218-0865 ext.226
    Address:
    9F., No.49, Dongxing Rd., Xinyi District, Taipei City, Taiwan R.O.C.
    Sectors:
    Automatically Precise Shockwave Medical Device
    Extracorporeal Shockwave Lithotripter (ESWL)
    Extracorporeal Shockwave Therapy (ESWT)
  • Mycenax Biotech

    Mycenax Biotech

    Company Description

    Mycenax as a bio-CMC based company, we are focusing on:
    1) CDMO service
    2) biological drug development including new biologics entities and biosimilars
    For CDMO services, we offer a one-stop shop and fully-integrated solution to serve various needs. Our facilities are PIC/S GMP certified and registered in USFDA and MHLW.
    For biological drug development, we have more than 10 pipelines mainly covered the field of oncology and autoimmune disease. The pipelines below are currently open for partnering.
    Pipelines (New biologics entities):
    ‧Launched: TuNEX (anti-TNF medication for treatment of rheumatoid arthritis)
    ‧Clinical phase: TuNEX (anti-TNF medication for treatment of ankylosing spondylitis)
    ‧Early stage R&D: MBI-002 (immune checkpoint agonist for the treatment of solid tumors) Pipelines (biosimilars):
    ‧Clinical phase: LusiNEX (tocilizumab)
    ‧Pre-IND: AiNEX (bevacizumab), GranNEX (filgrastim), Omalizumab

    Contact Information
    Name:
    Sunny Wang
    Position:
    Senior Specialist
    Tel:
    886-37-586-988 #1286
    Address:
    4F, No.50-7, keyan Road Jhuan Miaoli, Taiwan 35053
    Sectors:
    CDMO services
  • OBI Pharma, Inc.

    OBI Pharma, Inc.

    Company Description

    OBI Pharma, Inc., is a Taiwan biopharmaceutical company publicly-listed on the Taipei Exchange (TPex ticker: 4174). OBI’s mission is to develop and license novel therapeutic agents for unmet medical needs against cancer targets such as Globo Series (incl. Globo H, SSEA3, SSEA4) and AKR1C3. Globo Series and AKR1C3 are highly expressed in cancers of unmet need including Breast, Ovarian, Gastric, Lung, Liver Prostate and Esophageal. The company’s novel first-in-class oncology portfolio includes: Adagloxad Simolenin (formerly OBI-822; Globo H cancer vaccine), OBI-888 (Globo H mAb), OBI-999 (Globo H ADC), OBI-898 (SSEA4 mAb), OBI-866 (SSEA4 cancer vaccine), and OBI-3424 (small-molecule prodrug targeting AKR1C3 enzyme).

    Contact Information
    Name:
    Kevin Poulos
    Position:
    Chief Commercial Officer
    Tel:
    +001-619-537-7698
    Address:
    7F, No. 369, Sec. 7, Zhongxiao E Rd, Nangang Dist, Taipei City, Taiwan
    Sectors:
    Biopharmaceutical, New Drug Development, Oncology, Immuno-oncology, Novel Cancer Therapeutics
  • PharmaEssentia Corp.

    PharmaEssentia Corp.

    Company Description

    PharmaEssentia Corp. is a fully integrated global biopharmaceutical company headquartered in Taipei, Taiwan. It was established by a group of highly accomplished scientists from leading pharmaceutical companies, and led by seasoned executives with 100+ years of experience at biotechnology and regulatory agencies. The company aims to deliver efficacious, safe, and cost-effective therapeutic products to treat human disease, while bringing long lasting value to stakeholders.

    Ropeginterferon alfa-2b is a novel, mono-pegylated proline interferon alfa-2b invented by PharmaEssentia and manufactured at its own biologics facility in Taichung, Taiwan. The biologics facility had been certified by Taiwan Food and Drug Administration and European Medicines Agency, and is also designed and operated to be compliant with US FDA requirements.

    Contact Information
    Name:
    Shu-Fen Li
    Position:
    Senior Director – Marketing
    Tel:
    +1-857-373-9775
    Address:
    13F, No. 3, Park St., Nangang District, Taipei 115, Taiwan
    Sectors:
    Biopharmaceutical
  • Simpson Biotech Co., Ltd.

    Simpson Biotech Co., Ltd.

    Company Description

    Simpson Biotech Co., Ltd. (SBC), a private Co. founded in 1998, located in Taiwan is focusing on: (I). Medicinal fungus fermentation & enzymatically hydrolyzed bioactive natural ingredients used for dietary supplements & drug discovery. (II). OEM/ODM services for Recombinant Proteins (i.e. Industrial Enzymes), using a patented starch-binding protein as the affinity tag. New products launched in 2019: 1>. Potent anti-yeast & anti-bacteria soluble chitosan for food/drug & agriculture applications; 2>. World first high purity (chitobiose+chitotriose >90%) oligo chitosan for weight, diabetes and triglyceride control; 3.> Hydrolyzed Fucoidan for immune & glucose control. SBC has won numerous awards with 52 patents issued.

    Contact Information
    Name:
    Dr. Frank Chan
    Position:
    Project Manager
    Tel:
    886-3-3963466
    Address:
    No. 1-1 Wen Min 2nd St., Kuei Shan, Taoyuan 333, Taiwan, R.O.C.
    Sectors:
    1. Natural anti-yeast & bacteria agent
    2. Anti-inflammation drug discovery
    3. Natural dietary supplement
    4. Recombinant proteins OEM services
  • Soteria Biotechnology Co., Ltd.

    Soteria Biotechnology Co., Ltd.

    Company Description

    Soteria Biotech is a medical software developer founded in May 2016, experienced in medical image analysis, 3D reconstruction, computational fluid dynamics, cloud computing, big data analytics and AI. We combine aforementioned disciplines into an assistive software for use in the diagnosis and treatment of obstructive sleep apnea (OSA). Soteria has been granted Taiwan and US patents for the method used with its software. Domestically, winner of 2017 ICT Month Innovative Elite and StartUP@Taipei demo day pitch contest 2017. In an international level it has been awarded the 2017 APICTA Award in the category of health & wellbeing.

    Contact Information
    Name:
    Clovis M. Sinisterra S.
    Position:
    Business Development Manager
    Tel:
    886-2-2586-9959
    Address:
    12F, No. 365, Fude 3rd Rd., Xizhi Dist., New Taipei City
    Sectors:
    AI, Computational Fluid Dynamics, Medical Imaging, Big Data, Cloud Computing
  • TaiHao Medical Inc.

    TaiHao Medical Inc.

    Company Description

    TaiHao Medical Inc. is an artificial intelligence (AI) company founded in 2013, Taipei, Taiwan. The image processing methodology with AI is evaluated to be helpful in assisting physicians in breast cancer detection and diagnosis. The available products include "BR-Viewer" and "BR-FHUS Smart System" focusing on breast screening to meet the upcoming requirements. Either for automated breast ultrasound or hand-held ultrasound images, the corresponding computer-aided system is ready. We aim at being the leader of medical software with whole body health care in the world.

    Contact Information
    Name:
    Octavia Lin
    Position:
    Marketing Manager
    Tel:
    886-2-2736-5679 ext.16
    Address:
    3F.-8, No.100, Sec. 2, Heping E. Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C.)
    Sectors:
    Artificial Intelligence, Medical Imaging Software, Breast Ultrasound Software
  • TLC (Taiwan Liposome Company, Ltd.)

    TLC (Taiwan Liposome Company, Ltd.)

    Company Description

    We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).

    Our technologies can be used with a broad range of APIs and enable a simplified and scalable manufacturing process. Because our product candidates use already approved APIs, we are eligible to utilize the streamlined 505(b)(2) regulatory pathway for approval in the US. We have used our proprietary technology platforms to assemble a diverse product candidate portfolio that targets significant areas of unmet medical need.

    Contact Information
    Name:
    Lindsey Yang
    Position:
    Specialist
    Tel:
    886-2-2655-7377 #125
    Address:
    2F, 3 Yuanqu St., Nangang Dist., Taipei, Taiwan
    Sectors:
    Drug Delivery System
    Pain management
    Ophthalmology
    Oncology
  • TTY Biopharm Company Limited

    TTY Biopharm Company Limited

    Company Description

    TTY Biopharm is a Taiwan based pharmaceutical company advanced in long-acting special formulation drugs development, focus on Liposomal formulation and Microsphere platform and international marketing.

    Not only technology, TTY also developed Oncology and anti-critical Infection portfolio in Taiwan which is the number one domestic pharma in hospital sector, and major South-East Asian countries. To support commercial, TTY has two major manufacture sites. One is a dedicated cytotoxic plant and certified to meet US FDA, EMA and PMDA inspection standard for Oncology products. Another one is a dedicated non-cytotoxic plant and certified to meet PMDA inspection standard for non-cytotoxic products.

    Contact Information
    Name:
    Vincent Huang
    Position:
    Senior Manager
    Tel:
    886-2-2652-5999
    Address:
    3F., No. 3-1, Park St., Nangang Dist., Taipei City 11503, Taiwan
    Sectors:
    Finished Products Sales and Marketing, CMO/CDMO, Out-License collaboration
  • UnicoCell BioMed

    UnicoCell BioMed

    Company Description

    UnicoCell BioMed is a biomedical company in Taiwan and focus on stem cell drug development and cell therapy technology development. Our capabilities include our own R&D team, PIC/S GMP cell manufacturing facility, and sales & marketing team. Unique bioreactor based manufacturing technology allows us to mass produce high quality cell therapy product and high purity stem cell secretions. The main products and services are as follows:
    1. ”ELIXCYTE® ”, The new stem cell drug, is an allogeneic adipose stem cell product for the treatment of knee osteoarthritis and chronic kidney disease and is currently in the phase I/II clinical trials (phase I/II, US-FDA, TFDA IND ).
    2. "Unico-Vial” –Old school, new design/patented cyrotube & Drug container , is an ideal biopreservation container system for cell therapy product, providing for closure integrity, sample stability and ready access to clinical use
    3. “Perfectin® ” –Industrial production of Adipose stem cell derived factors and exosomes for cosmetic & medicinal use.
    4. Licensed autologous cell therapy services.

    Contact Information
    Name:
    Chris Tsai
    Position:
    RD Director
    Tel:
    886-2-2792-2699 #133
    Address:
    6F., No. 65, Ln. 77, Xing’ai Rd., Neihu Dist., Taipei City 114, Taiwan (R.O.C.)
    Sectors:
    New drug development, Cell therapy products, Stem cell technology

Incentives

  • Taiwan delegation & events in Philadelphia during BIO 2019
    Size: 5.4mb | PDF
  • 2019 Introduction to Biotechnology and Pharmaceutical Industries in Taiwan
    Size: 4.09mb | PDF
  • TAIWAN, invest your healthcare and life quality
    Size: 13.4mb | PDF

Contact

The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) is the single contact window for Taiwan's biomedical industry. It is an one-stop service window designed to assist companies in the biomedical industries worldwide.

The assistances provided by BPIPO include: financial support, investment promotion, stock listing, personnel training and recruitment, R&D collaboration, technology transfer, commercialization, marketing, promotion activities, strategic alliances, and others.